MTOR, mechanistic target of rapamycin kinase, 2475

N. diseases: 960; N. variants: 48
Disease: cervical cancer ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4048328
Disease: cervical cancer
cervical cancer 		0.340 Biomarker disease BEFREE Taken together, 1 may be a potential mTOR inhibitor used for the treatment of cervical cancer. 30623680 2019
CUI: C4048328
Disease: cervical cancer
cervical cancer 		0.340 AlteredExpression disease BEFREE An in vitro model of cervical cancer was established using HeLa and CaSki cells. mTOR protein expression as well as autophagy-related proteins were evaluated through Western blotting. 26201060 2015
CUI: C4048328
Disease: cervical cancer
cervical cancer 		0.340 AlteredExpression disease BEFREE In general, SPAG5 upregulation relates to poor prognosis in cervical cancer patients, and SPAG5 is a regulator of mTOR activity during taxol treatment in cervical cancer. 24853425 2014
CUI: C4048328
Disease: cervical cancer
cervical cancer 		0.340 Biomarker disease BEFREE Inhibition of mTOR represents a potential therapeutic strategy for cervical cancers. 20102778 2010
CUI: C4048328
Disease: cervical cancer
cervical cancer 		0.340 Biomarker disease CTD_human Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy. 18058806 2008